Skip to content

Assessing the Predictive Value of High Frequency Algorithm of PURE EP for Low Amplitude Signal Detection

To Assess the Predictive Value of High Frequency Algorithm of PURE EP for Low Amplitude Signal Detection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05450302
Enrollment
150
Registered
2022-07-08
Start date
2023-04-30
Completion date
2023-12-31
Last updated
2023-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrhythmias

Brief summary

Prior multicenter study demonstrated superiority of PURE EP to conventional mapping. This superiority was seen when comparing small, fractionated signals of interest, near-field vs far-field distinction, and general signal quality (2). Hence, investigators propose a retrospective study to assess the predictive value of high frequency algorithm (HFA) for identifying local physiologic signal under 0.3 mV distinctive of noise.

Detailed description

Accurate interpretation of intracardiac EGMs remains essential to the field of electrophysiology (EP). Conventional Electro-anatomical mapping systems (EAMs) have made significant improvements in EGM quality and noise reduction since their emergence, however their use of variable gain amplifiers and high/low pass filters, often provide visualization of low amplitude signals that lead to saturation artifact or necessitate signal clipping. PURE EPTM (BioSig Technologies, Inc., Westport, CT, USA), in contrast does provide the ability to record this unaltered signal with more customizable display options. Their proprietary amplifier and high-resolution analog-digital converters with Radiofrequency (RF) suppression eliminates the need for gain switching, optimizing resolution of the full range of input signals (1). Prior multicenter study demonstrated superiority of PURE EP to conventional mapping. This superiority was seen when comparing small, fractionated signals of interest, near-field vs far-field distinction, and general signal quality (2). Hence, investigators propose a retrospective study to assess the predictive value of high frequency algorithm (HFA) for identifying local physiologic signal under 0.3 mV distinctive of noise.

Interventions

OTHERPURE EP (Observational Study)

This is an observational study. No interventions involved in this study.

Sponsors

Kansas City Heart Rhythm Research Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All patients (male + Female) with age \> 18 years from January 2022 till June 2022 will be included in the study.

Exclusion criteria

All patients in which PURE EP was not used from January 2022 till June 2022.

Design outcomes

Primary

MeasureTime frameDescription
Predictive value of High Frequency Algorithm - for signals under 0.3mV distinctive of noise1/1/2022 - 6/30/2022Validate the predictive value of High Frequency Algorithm (HFA) for identifying local physiologic signals under 0.3mV distinctive of noise.
Predictive value of High Frequency Algorithm - for signals under 0.1mV distinctive of noise1/1/2022 - 6/30/2022Validate the predictive value of High Frequency Algorithm (HFA) for identifying local physiologic signals under 0.1mV distinctive of noise
Sensitivity and specificity1/1/2022 - 6/30/2022Percen of sensitivity and specificity of predicting a small physiologic signal distinctive from noise

Secondary

MeasureTime frameDescription
Bipolar amplitude1/1/2022 - 6/30/2022The measurement tool, specifically within PURE EP, called Horizontal Caliper Mode similar to that of recording and mapping systems, will measure the millivolt peak-to-peak amplitude of the bipolar signal, which is identified by its electrode numbers.
Channel of the Bipolar1/1/2022 - 6/30/2022It depends on which channel has the low amplitude signal and it may change based on the signal. It is measured by Horizontal Caliper Mode '' in millivolts in the PURE EP program.

Countries

United States

Contacts

Primary ContactDonita Atkins
Datkins@kchrf.com816-651-1969

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026